ANK1 Gene Spherocytosis Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS laboratory.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic post-test consultation with a DHA-licensed medical genetics consultant.
Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The ANK1 gene spherocytosis type 1 genetic test uses next‑generation sequencing (NGS) to identify pathogenic variants in the ANK1 gene, confirming hereditary spherocytosis with greater than 99.9% analytical accuracy. This DNA test analyses the entire coding region and splice sites to detect even rare mutations, providing a definitive diagnosis when clinical signs and family history suggest spherocytosis. Results are interpreted in the context of complete blood count, reticulocyte count, and family pedigree.

Feature	Our ANK1 NGS Test	Alternative (Sanger Sequencing)
Precision / Coverage	Full exon coverage + splice sites; 99.9% sensitivity	Partial gene coverage; ~90% sensitivity
Methodology	NGS (Next‑Generation Sequencing) – targeted panel	Sanger sequencing (one region at a time)
Turnaround Time	3 to 4 weeks	4 to 6 weeks
Regulatory Compliance	DHA, MOHAP, ISO 9001:2015	Often lacks UAE-specific licensing

Physician Insight & Safety Protocols

Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403

“Waiting for genetic results can feel like standing at the edge of uncertainty. I want you to know that a positive result is not a conclusion — it is the beginning of precise, personalised care. Please discuss all findings with a genetic counsellor to understand how they affect your health and your family’s future; never make treatment decisions without your doctor.”

Medication & Clinical Advisory

Do not discontinue or adjust any prescribed medication without consulting your treating physician.

Inform your genetic counsellor about all current medications, including anticoagulants, before sample collection.
Results from this test should be correlated with a complete blood count, reticulocyte count, and family pedigree before any clinical decision is made.
Always carry a copy of your genetic report when visiting any healthcare provider for ongoing management.

Exclusion Criteria & Emergency Red Flags

No absolute exclusion exists. However, if you are experiencing an acute hemolytic crisis with severe anemia (Hb <7 g/dL) or jaundice, genetic testing should be deferred until stabilisation.

ER Red Flags: Sudden dark urine, rapid onset of pallor, severe fatigue, abdominal pain, or confusion — go to the emergency room immediately. These may indicate a hemolytic episode requiring urgent care.
Cold-Chain Integrity: Home collection uses ISO-certified temperature-controlled transport; FTA card samples are stable at ambient temperature, but whole blood must be processed within 24 hours.
Minors: Parental or guardian consent is mandatory for all individuals under 18 years of age, in accordance with UAE child protection regulations.

Patient FAQ & Clinical Guidance

1. What is the ANK1 gene spherocytosis type 1 test?

This test uses next‑generation sequencing to detect disease‑causing mutations in the ANK1 gene, which is responsible for hereditary spherocytosis type 1 — a red blood cell membrane disorder. Analysing the entire coding region and splice sites, the test provides a definitive diagnosis when clinical signs and family history suggest spherocytosis. Results are interpreted alongside complete blood count, reticulocyte count, and pedigree analysis.

2. How do I prepare for the test and what does home collection involve?

No fasting is required. A certified phlebotomist will visit your home to draw a venous blood sample or collect a finger‑prick on an FTA card using ISO‑certified cold‑chain logistics. Please provide your clinical history and any previous blood reports. If you take anticoagulants, inform the collector beforehand. The VIP mobile service operates from 8 AM to 11 PM, and samples are transported in validated coolers to our ISO‑accredited laboratory.

3. What do my results mean and what happens next?

A positive report indicates you carry a disease‑causing ANK1 variant, confirming hereditary spherocytosis. A genetic counsellor will explain the inheritance risks and implications for family members. Results are classified as pathogenic, likely pathogenic, or a variant of uncertain significance (VUS). Even if no mutation is found, spherocytosis may still be caused by other genes. Post‑test clinical guidance with our DHA‑licensed consultant helps you understand surveillance, treatment options, and preventive measures.

UAE Regulatory & Data Privacy Adherence

Data Privacy & Health Information Protection

This laboratory and all associated procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted, access‑controlled, and processed solely for diagnostic purposes.

Licensed by DHA (Facility No. 1143) · ISO 9001:2015 accredited · Minors testing requires parental consent under UAE child protection laws.

Clinical & Logistical Metadata

Test Name	ANK1 Gene Spherocytosis Type 1 Genetic Test
Price (AED)	2,800
Turnaround Time	3 to 4 Weeks
Sample Type / Matrix	Peripheral Whole Blood (Venipuncture) or FTA Card (Finger‑Prick)
Methodology Used	Next‑Generation Sequencing (NGS) – Targeted Gene Panel
ICD-10-CM Code	D58.0
LOINC Code	21673-3
DHA Facility License & Laboratory Address	DHA License No. 1143 \| DNA Labs UAE \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE